3+ day, 16+ hour ago   (38+ words) Biparatopic HER2 Targeting in Action: Anbenitamab’s Phase 3 Breakthrough Docwire News Biparatopic HER2 Targeting in Action: Anbenitamab’s Phase 3 Breakthrough Shao ZM, et al. Basch E, et al. 2026 American Society of Clinical Oncology Annual Meeting. Abstract LBA660....

3+ day, 16+ hour ago   (290+ words) Jeffrey Hyams, MD, of the University of Connecticut and Connecticut Children’s Hospital in Hartford, Connecticut, shares results from the UNIFI JR trial evaluating ustekinumab in pediatric patients with ulcerative colitis who did not respond to conventional therapies. From these results…...

3+ day, 16+ hour ago   (146+ words) Adam Faye, MD, of NYU Langone Health, New York, New York, shares results from a study evaluating the safety of guselkumab among older populations of patients with immune-mediated inflammatory diseases, such as inflammatory bowel disease (IBD), psoriasis, and psoriatic arthritis....

3+ day, 16+ hour ago   (427+ words) The following transcript has been edited for clarity. Can you elaborate a little on what the results tell us about survodutide’s unique dual glucagon/GLP-1 mechanism? Dr. Le Roux: Yeah, because survodutide acts like an oxyntomodulin analog, a natural gut…...

5+ day, 10+ hour ago   (294+ words) The development of immune checkpoint inhibitors, specifically pembrolizumab used alone or in combination with chemotherapy, has improved outcomes for selected patients with triple-negative breast cancer (TNBC). Despite this success, patients still develop primary or acquired resistance. In a recent review…...

1+ week, 6+ day ago   (350+ words) Cindy Zadikoff, MD, MSc, executive medical director at AbbVie, discusses recent results of the TEMPO-2 trial. Here, she shares what tavapadon use means for clinicians treating early Parkinson’s disease, how to balance tolerability and efficacy in clinical practice, the drug’s…...

3+ week, 5+ day ago   (226+ words) Therapies currently used to treat myasthenia gravis (MG) are limited by their short-term efficacy and may not be readily available in plasma exchange settings. In light of this, other approaches to treating MG are needed. In a prospective study published…...

3+ week, 5+ day ago   (221+ words) The study, conducted in the second year of vaccine distribution, included 639 individuals selected from the German general population. Participants had a mean age of 37.04 years, 77.8% were female, and 24.4% self-reported a mental illness. Initially, 715 individuals participated in the study, but 76 were…...

1+ mon, 4+ day ago   (115+ words) In a cohort study, investigators found that respiratory tract infections early in life are associated with development of atopic dermatitis in childhood. In VDAART, children in the upper tertiles of infection episodes and days, had higher risk for atopic dermatitis…...

1+ mon, 2+ week ago   (261+ words) Primary immune thrombocytopenia (ITP) is a rare immune disorder in which patients experience heavy bleeding symptoms, such as severe nosebleeds, bleeding gums, and heavy menstrual bleeding. The acute form of ITP tends to affect children more frequently than adults; approximately…...